AngioDynamics (ANGO)
(Delayed Data from NSDQ)
$6.17 USD
+0.05 (0.82%)
Updated May 24, 2024 04:00 PM ET
After-Market: $6.18 +0.01 (0.16%) 7:58 PM ET
4-Sell of 5 4
C Value D Growth B Momentum D VGM
Cash flow Statements
Fiscal Year End for AngioDynamics, Inc falls in the month of May.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
5/31/2023 | 5/31/2022 | 5/31/2021 | 5/31/2020 | 5/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -52.44 | -26.55 | -31.55 | -166.79 | 61.34 |
Depreciation/Amortization & Depletion | 45.42 | 29.35 | 25.92 | 23.81 | 25.88 |
Net Change from Assets/Liabilities | -7.03 | -21.05 | 9.07 | -28.55 | -1.26 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 14.12 | 11.05 | 20.65 | 156.98 | -48.52 |
Net Cash From Operating Activities | 0.08 | -7.19 | 24.09 | -14.55 | 37.44 |
Property & Equipment | -3.81 | -4.30 | -5.19 | -7.24 | -3.12 |
Acquisition/ Disposition of Subsidiaries | 0.00 | -3.60 | 0.00 | -55.76 | 84.32 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 1.35 |
Other Investing Activities | -5.93 | -11.41 | -8.52 | -0.35 | 169.24 |
Net Cash from Investing Activities | -9.75 | -19.31 | -13.71 | -63.35 | 82.55 |
Uses of Funds
5/31/2023 | 5/31/2022 | 5/31/2021 | 5/31/2020 | 5/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.00 | 2.68 | 3.01 | -0.76 | 2.03 |
Issuance (Repayment) of Debt | 25.00 | 5.00 | -20.00 | -92.50 | 40.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.42 | 0.00 | 0.00 | -1.98 | -8.10 |
Net Cash from Financing Activities | 25.42 | 7.68 | -16.99 | -95.24 | 33.93 |
Effect of Exchange Rate Changes | 0.04 | -0.52 | 0.33 | -0.07 | -0.38 |
Net Change In Cash & Equivalents | 15.80 | -19.34 | -6.27 | -173.21 | 153.55 |
Cash at Beginning of Period | 28.83 | 48.16 | 54.44 | 227.64 | 74.10 |
Cash at End of Period | 44.62 | 28.83 | 48.16 | 54.44 | 227.64 |
Diluted Net EPS | -1.33 | -0.68 | -0.82 | -4.39 | 1.64 |
Fiscal Year End for AngioDynamics, Inc falls in the month of May.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
2/29/2024 | 11/30/2023 | 8/31/2023 | 5/31/2023 | 2/28/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -170.90 | 16.84 | 45.88 | -52.44 | -30.98 |
Depreciation/Amortization & Depletion | 20.90 | 13.37 | 6.69 | 45.42 | 23.32 |
Net Change from Assets/Liabilities | 4.70 | -14.11 | -22.12 | -7.03 | -19.00 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 112.15 | -36.73 | -56.35 | 14.12 | 10.78 |
Net Cash From Operating Activities | -33.16 | -20.63 | -25.90 | 0.08 | -15.88 |
Property & Equipment | 132.55 | 98.66 | 99.21 | -3.81 | -2.76 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | -0.54 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | -6.50 | -2.01 | -0.77 | -5.93 | -4.92 |
Net Cash from Investing Activities | 126.05 | 96.65 | 98.44 | -9.75 | -8.22 |
Uses of Funds
2/29/2024 | 11/30/2023 | 8/31/2023 | 5/31/2023 | 2/28/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.75 | 0.06 | 0.41 | 0.00 | 1.17 |
Issuance (Repayment) of Debt | -50.00 | -50.00 | -50.00 | 25.00 | 25.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -10.00 | -10.00 | -10.00 | 0.42 | -0.75 |
Net Cash from Financing Activities | -59.25 | -59.94 | -59.59 | 25.42 | 25.42 |
Effect of Exchange Rate Changes | 0.19 | 0.20 | 0.01 | 0.04 | -0.04 |
Net Change In Cash & Equivalents | 33.83 | 16.28 | 12.97 | 15.80 | 1.29 |
Cash at Beginning of Period | 44.62 | 44.62 | 44.62 | 28.83 | 28.83 |
Cash at End of Period | 78.45 | 60.90 | 57.59 | 44.62 | 30.11 |
Diluted Net EPS | -4.67 | -0.72 | 1.15 | -0.55 | -0.24 |